Pharming Group to participate in September investor conferences
September 04 2024 - 1:00AM
Leiden, the Netherlands, September 4,
2024: Pharming Group N.V. (“Pharming”) (Euronext
Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management
will participate in the following investor conferences in the U.S.
in the month of September:
- 2024 Wells
Fargo Healthcare Conference, Boston, September 4-6Sijmen
de Vries, Chief Executive Officer, will participate in a fireside
chat question and answer session on Friday, September 6 at 08:45 AM
ET/14:45 CET. A live webcast and replay of the presentation will be
available in the “Upcoming Events” and “News” sections of
Pharming’s website.
- H.C.
Wainwright 26th Annual Global
Investment Conference, New York, September 9-11Sijmen de
Vries, Chief Executive Officer, will present on Monday, September 9
at 10:30 AM ET/16:30 CET. A live webcast and replay of the
presentation will be available in the “Upcoming Events” and “News”
sections of Pharming’s website.
For more information about these conferences, or
to schedule a one-to-one meeting with Pharming’s management team,
please contact Pharming’s Investor Relations team at
investor@pharming.com or your Wells Fargo or H.C. Wainwright
representative.
About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam:
PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated
to transforming the lives of patients with rare, debilitating, and
life-threatening diseases. Pharming is commercializing and
developing an innovative portfolio of protein replacement therapies
and precision medicines, including small molecules and biologics.
Pharming is headquartered in Leiden, the Netherlands, and has
employees around the globe who serve patients in over 30 markets in
North America, Europe, the Middle East, Africa, and
Asia-Pacific.
For more information, visit www.pharming.com and
find us on LinkedIn.
For further public information,
contact:
Pharming Group, Leiden, the NetherlandsMichael
Levitan, VP Investor Relations & Corporate CommunicationsT: +1
(908) 705 1696E: investor@pharming.com
FTI Consulting, London, United KingdomVictoria
Foster Mitchell/Alex Shaw/Amy ByrneT: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam,
the NetherlandsLeon MelensT: +31 6 53 81 64 27E:
pharming@lifespring.nl
- Pharming attending Investor Conferences September
2024_EN_2SEP24
Pharming Group NV (EU:PHARM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pharming Group NV (EU:PHARM)
Historical Stock Chart
From Sep 2023 to Sep 2024